In in vitro experiments, the knockdown of EIF2β changed the phenotype of somatotroph adenomas, including cell proliferation, migration, and the secretion ability of growth hormone/insulin-like growth factor-1. The gene discussed is IGF1; the disease is growth hormone-secreting pituitary adenoma.